Alaunos Therapeutics, Inc. (TCRT) › EPS (Diluted)Alaunos Therapeutics, Inc. (TCRT) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2016: $-1.322017: $-0.532018: $0.962019: $-0.702020: $-0.382021: $-0.372022: $-2.612023: $-21.972024: $-2.922025: $-2.20$-2.202016EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-2.20+24.7%2024$-2.92+86.7%2023$-21.97-741.8%2022$-2.61-605.4%2021$-0.37+2.6%2020$-0.38+45.7%2019$-0.70-172.9%2018$0.96+281.1%2017$-0.53+59.8%2016$-1.32—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share